Boyd Martin and his mount Blackfoot Mystery, owned by the Blackfoot Mystery Syndicate,
repeated victory to win the Asheville Regional Airport Wellington Eventing Showcase held at the
2016 Adequan Global Dressage Festival.
The Winning Formula
for Champions
The ONLY FDA approved equine PSGAG
for the intramuscular treatment of non-
infectious degenerative joint disease (DJD)
of the carpal and hock joints proven to:
• DIMINISH the destructive processes
of degenerative joint disease
• REVERSE the processes which result
in the loss of cartilage components
• IMPROVE overall joint function and
associated lameness
Available for order! For more information
about equine joint health and treatment
with Adequan
®
i.m., please visit
www.adequan.com.
Adequan
®
and the Horse Head design are registered trademarks of Luitpold Pharmaceuticals, Inc.
© Luitpold Animal Health, division of Luitpold Pharmaceuticals, Inc. 2016. Blackfoot Mystery, owned by the
Blackfoot Mystery Syndicate. Image of Boyd Martin © Susan Stickle used with permission. AHD243 Iss. 4/2016
INDICATIONS
For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness
of the carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Adequan
®
i.m. brand Polysulfated
Glycosaminoglycan in horses. Studies have not been conducted to establish safety in breeding horses. WARNING: Do
not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the
reach of children. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Please see Full Prescribing Information at www.adequan.com.
